Availability and use of non-prescribed buprenorphine-naloxone in a Canadian setting, 2014–2020
International Journal of Drug Policy(2022)
摘要
•The availability of non-prescribed BUP-NX increased in Vancouver between 2014 and 2020.•This rise in BUP-NX availability was not associated with an increase in use.•Availability was associated with variables suggestive of more severe substance use.•BUP-NX is a first line treatment option, but may not be desirable to all patients.
更多查看译文
关键词
Buprenorphine,Opioid-related disorders,Opioid agonist therapy,Prescription drug diversion
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要